Eagle Pharmaceuticals Inc. (EGRX)

78.14 -2.47 (-3.064%)

IEX Real-Time Price

August 17, 2018 EST.

NASDAQ Global Market : Healthcare

Prev Close 80.61

Price Open 80.65

Volume: 294,010

Avg Volume: 234,253

Market Cap: 1.18B

P/E Ratio 34.73

52 Wk Range 48.84-85.66



EGRX Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-07-31
13.54M
2.44M
11.34
17.99%

2018-07-13
13.32M
2.4M
9.54
17.99%

2018-06-29
13.32M
2.55M
9.46
19.14%

2018-06-15
13.32M
2.59M
10.07
19.46%




EGRX Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-05-14
Q1 2018
N/A
0.81 (1)
0.00
0.00

2018-05-10
Q1 2018
BTO
0.33 (1)
0.17
-0.16

2018-03-07
Q4 2017
N/A
1.19 (2)
0.84
-0.19

2018-02-26
Q4 2017
BTO
1.19 (2)
0.84
-0.19

News

Investors shun healthcare stocks in broad market selloff (2018-08-15 10:14 SeekingAlpha)

Healthcare stocks are taking it on the chin in today's broad selloff, some more than others. The SPDR S&P Biotech ETF ( XBI -2% ), for example, is down more than the major indexes. More news on: SPDR Biotech ETF, Ionis Pharmaceuticals, Inc., Global Blood Therapeutics, Healthcare stoc…

 


Statistics

Shares Outstanding: 15.06M

Top 15 Institution Percent: N/A

Price To Sales: 5.63

Price To Book: 6.33

Revenue: 63.02M

Gross Profit: 51.36M

Cash: 97.55M

Debt: 48.94M

Return On Assets: 12.06

Return On Equity: 16.97

Profit Margin: 13.81

Price History

Beta: 1.37

50-day Moving Avg: 77.74

200-day Moving Avg: 62.81

YTD Change: 34.24

5-day Change: -0.96

1-month Change: -4.68

3-month Change: 13.92

6-month Change: 24.13

1-year Change: 39.49

Revenue Per Share: 4.00

Revenue Per Employee: 583528.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Eagle Pharmaceuticals Inc.

Exchange: NASDAQ Global Market

Industry: Drug Manufacturers

Sector: Healthcare

Website: http://www.eagleus.com

Eagle Pharmaceuticals Inc is a specialty pharmaceutical company. The company develops and commercializes injectable products in the areas of critical care, orphan diseases, and oncology.